1. Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management;Rawat;Biomed Pharmacother,2021
2. Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice;Obata;Eur J Prev Cardiol,2020
3. IFN-γ-STAT1-ERK pathway mediates protective effects of invariant natural killer T cells against doxorubicin-induced cardiomyocyte death;Sada;J Am Coll Cardiol Basic Trans Science,2023
4. Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury;Guo;J Am Coll Cardiol Basic Trans Science,2023
5. Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity;Ozcan;Cell Metab,2023